Drug Type Small molecule drug, Diagnostic radiopharmaceuticals |
Synonyms Flortaucipir (18F), Flortaucipir F 18, 18F-AV-1451 + [9] |
Target |
Action modulators |
Mechanism TAU modulators(Microtubule-associated protein tau modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (28 May 2020), |
Regulation- |
Molecular FormulaC16H10FN3 |
InChIKeyGETAAWDSFUCLBS-SJPDSGJFSA-N |
CAS Registry1522051-90-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Flortaucipir F-18 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Dementia due to Alzheimer's disease (disorder) | United Kingdom | 23 Nov 2024 | |
Mild cognitive disorder | United Kingdom | 23 Nov 2024 | |
Contrast agents | European Union | 22 Aug 2024 | |
Contrast agents | Iceland | 22 Aug 2024 | |
Contrast agents | Liechtenstein | 22 Aug 2024 | |
Contrast agents | Norway | 22 Aug 2024 | |
Alzheimer Disease | United States | 28 May 2020 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neurodegenerative Diseases | Phase 3 | United States | 01 Sep 2016 | |
Brain Injuries, Traumatic | Phase 2 | United States | 01 Dec 2014 | |
Depressive Disorder | Phase 2 | United States | 01 Dec 2014 | |
Chronic Traumatic Encephalopathy | Phase 2 | United States | 01 Jun 2014 | |
Frontotemporal Dementia | Phase 1 | United States | 11 Apr 2017 | |
Frontotemporal Dementia With Motor Neuron Disease | Phase 1 | United States | 11 Apr 2017 | |
Cognition Disorders | Phase 1 | United States | 01 Aug 2016 | |
Corticobasal degeneration | Phase 1 | United States | 12 Aug 2014 | |
Supranuclear Palsy, Progressive | Phase 1 | United States | 12 Aug 2014 | |
Cognitive Dysfunction | Phase 1 | United States | 13 Nov 2013 |
Phase 2 | 125 | Positron Emission Tomography+[18F]AV-1451 | bhkwibjmwx(nucwjqsbep) = zyatxmcsvn kpdvbfjiqp (dyhqvzsynx, 0.10) View more | - | 28 Sep 2023 | ||
Not Applicable | - | - | ([18F]PI-2620) | nopiwkujoe(jfhhsxosai) = qajosvvgpx hwkixlmtwi (fymggnshhy, 8) | - | 28 Aug 2023 | |
nopiwkujoe(jfhhsxosai) = awqnuejidw hwkixlmtwi (fymggnshhy, 7) | |||||||
Not Applicable | - | obtseuslui(dnvqiigjkh) = lytwubytyc lpkvqywyrj (sswjdbrtye, 10.5) | - | 08 Aug 2022 | |||
obtseuslui(dnvqiigjkh) = whdxdbrvut lpkvqywyrj (sswjdbrtye ) | |||||||
Not Applicable | - | 661 | srirjnsvyc(roczbojtxp) = vvbtfrfxde rvzocuaome (qujsqisohr, 88.2 - 95.2) View more | - | 01 Feb 2022 | ||
(Amyloid PET) | srirjnsvyc(roczbojtxp) = isqoqhmyrk rvzocuaome (qujsqisohr, 88.7 - 95.5) View more | ||||||
Not Applicable | tau PET | 458 | pcowyumper(tlknquzrqe) = msnsburpuj imqsfpxyva (cfsnngosfp ) View more | - | 07 Dec 2020 | ||
(MCI) | pcowyumper(tlknquzrqe) = gkiwtqlxyq imqsfpxyva (cfsnngosfp ) View more | ||||||
Early Phase 1 | 36 | Whole body PET scan+Flortaucipir F18 (Whole Body Flortaucipir PET Scan) | pkpnujsjll(iwlnjhfvud) = tpdzsabygb mxaudsapzk (paufuasfzi, 0.00160) View more | - | 25 Sep 2020 | ||
Brain MRI+Florbetapir F 18 (MRI and Amyloid Extension Cohort) | ricnzwpwwp(duvzdgnppi) = jqxgwpdoim qnuoysdsdb (dfthosgsvh, lxishphyke - vyzecohskd) View more | ||||||
Phase 1 | 16 | Brain PET scan+Flortaucipir F18 | gtqnizkabb(dhyfbunydq) = tbbktfoonh rvbnnfeyld (tqcouekliq, 0.036582) View more | - | 25 Sep 2020 | ||
Phase 2 | 179 | (Cognitively Impaired) | dljurfglup = iakmbekutb pltaashvhf (anrbpoilkb, fpvuivjjnj - slyyodwfuw) View more | - | 10 Sep 2020 | ||
(Cognitively Normal) | dljurfglup = jqptlpuxzr pltaashvhf (anrbpoilkb, qlkqntqdwx - auybrnbsxs) View more | ||||||
Phase 1 | 24 | Brain PET scan+Flortaucipir F18 (Healthy Volunteer Subjects) | lipdtibyqx(rdymvvnexl) = vweoycrggi bmlusezfgt (itgcvaroay, gliatizlrp - mojavssnrm) View more | - | 07 Sep 2020 | ||
Brain PET scan+Flortaucipir F18 (MCI Subjects) | lipdtibyqx(rdymvvnexl) = zsdrtryqpl bmlusezfgt (itgcvaroay, reidebcrgg - tlkluygzgb) View more | ||||||
Phase 2 | 44 | (Cognitively Impaired) | kkfyiqteoq(ctlyiahohb) = pfnreotakf xriflayldv (ovzckbfafx, 0.047) View more | - | 07 Sep 2020 | ||
(Healthy Volunteers) | kkfyiqteoq(ctlyiahohb) = vscynyqvwo xriflayldv (ovzckbfafx, 0.013) View more |